St-Laurent, Canada

Wuyi Wang


Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1997-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Wuyi Wang: Innovator in Pharmaceutical Chemistry

Introduction

Wuyi Wang is a notable inventor based in St-Laurent, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 4 patents to his name, Wang's work has the potential to impact the medical community significantly.

Latest Patents

Wuyi Wang's latest patents include innovative compounds such as isoquinolines, which are useful as analgesics. Additionally, he has developed antineoplastic heteronapthoquinones. This invention relates to naphthoquinone derivatives, processes, and intermediates for preparing these derivatives. Furthermore, it encompasses pharmaceutical compositions and the use of these derivatives as antitumor agents in mammals.

Career Highlights

Throughout his career, Wuyi Wang has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Biochem Pharma Inc. and Astra AB. His work in these organizations has allowed him to advance his research and contribute to the development of new therapeutic agents.

Collaborations

Wuyi Wang has collaborated with several professionals in his field. Some of his notable coworkers include Giorgio Attardo and Marc Courchesne. These collaborations have likely enriched his research and led to innovative solutions in pharmaceutical chemistry.

Conclusion

Wuyi Wang is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important therapeutic compounds. His contributions, particularly in the area of analgesics and antitumor agents, highlight his role as a key innovator in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…